The Relationship Between Irisin and Bone Health in Individuals With Spinal Cord Injury
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 11 people enrolled
- Started
- 5 May 2023
- Ended
- 30 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Acute Exercise
- Record updated
- 1 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (28)Hide the full registry criteria
Who can take part
- Participants with SCI:
- age 18 years or older
- traumatic SCI at the cervical level 4 or lower that occurred at least 12 months prior to the start of the study
- American Spinal Injury Association Impairment Scale A, B or C
- uses a manual wheelchair as primary means of mobility (30+ hours per week)
- is able to perform a transfer independently to and from a wheelchair
- has adequate strength and upper extremity function to operate an arm ergometer; Control Participants:
- age and sex-matched to participant with SCI
Who cannot take part
- active use of medications which potentially affect bone metabolism, including: parathyroid hormone and analogs, androgenic or estrogenic steroids, bisphosphonates, oral glucocorticoids (use for more than 3 months)
- active use of medications which potentially affect bone metabolism, including: parathyroid hormone and analogs, androgenic or estrogenic steroids, bisphosphonates, oral glucocorticoids (use for more than 3 months)
- history of fractures or dislocations in the upper extremity from which the participant has not fully recovered
- history of coronary artery disease, coronary bypass surgery or other cardiorespiratory events or conditions
- endocrinopathy or metabolic disorders of the bone; e.g. Paget's disease, renal bone disease
- history of allergic reaction to lidocaine
- any other conditions that the person's primary care physician deems is a contraindication to participation in arm ergometry exercise stress testing or vigorous exercise
- history of neuromuscular conditions which could influence muscle gene expression
- history of lower body musculoskeletal injuries from which the participant has not fully recovered
- history of allergic reaction to lidocaine
- any other conditions that the person's primary care physician deems is a contraindication to the performance of a vastus lateralis muscle biopsy
- Participants with SCI:
- upper limb pain or injury that interferes with the ability to perform aerobic exercise
- recent hospitalization for any reason (within the past three months)
- likely to experience clinically significant autonomic dysreflexia and/ or orthostatic hypotension in response to vigorous exercise
- pregnant
- participation in another "Greater than Minimal Risk" study; Control Participants:
- recent hospitalization for any reason (within the past three months)
- pregnant
- participation in another "Greater than Minimal Risk" study
Where in United States
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, United States
About the trial
What the trial wants to find out
This study will examine the relationship between circulating irisin and bone health individuals with spinal cord injury. Additionally, this study seeks to examine the influence of muscle fiber type on circulating irisin and identify an exercise-based means to increase irisin concentrations.
The 2 groups in the trial
- Individuals with SCIExisting treatment, for comparison
Male and female, Veteran and non-Veteran participants with traumatic SCI will complete the baseline blood draw, muscle biopsy and DXA/HR-pQCT bone imaging. This group will complete blood draws before and after arm ergometer high-intensity interval exercise bout.
Treatment: Acute Exercise
- Controls (No SCI)Existing treatment, for comparison
Male and female Veterans, age and sex-matched to participants with SCI will complete the baseline blood draw, muscle biopsy and DXA/HR-pQCT bone imaging. This group will complete blood draws before and after arm ergometer high-intensity interval exercise bout.
Treatment: Acute Exercise
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Influence of Irisin/FNDC5 on Bone Mineral Density and Fracture Risk in Individuals With Spinal Cord Injury
- Record updated
- 1 September 2026